Modis Therapeutics competitors and similar companiesClear all

Bluebird Bio's competitors and similar companies include Ultragenyx Pharmaceutical.
Bluebird Bio
Bluebird Bio
Bluebird Bio is a developer of gene therapies for severe genetic diseases and cancer.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Founding Date
Founding Date
1992
Founding Date
2010
Type
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Paris, FR
München, DE
Athens, GR
Milano, IT
Utrecht, NL
Zug, CH
see more
Locations
Novato, US HQ
Employees
Employees
1,2134% increase
Employees
74021% increase
Valuation ($)
Valuation ($)
443.8 m
Valuation ($)
2.8 b
Alexa Website Rank
Alexa Website Rank
438682
Alexa Website Rank
493642
Employee Rating
Employee Rating
3.6
Employee Rating
4.3

Financial

Revenue (est.)
Revenue (est.)
$3.7m (FY, 2021)
Revenue (est.)
$351.4m (FY, 2021)
Net income
Net income
($819.4m) (FY, 2021)
Net income
($454m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 409m
Total funding raised
$ 200.1m
For sources of this data, please see the company profile

View company profiles

Ultragenyx Pharmaceutical
HQ
Novato, US
Employees
740↑ 21% increase

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

View company